ID   CCNL1_RAT               Reviewed;         527 AA.
AC   Q9R1Q2; Q5U364;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   29-MAY-2024, entry version 156.
DE   RecName: Full=Cyclin-L1;
DE            Short=Cyclin-L;
DE   AltName: Full=Cyclin Ania-6a;
GN   Name=Ccnl1; Synonyms=Ania6a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   INDUCTION.
RX   PubMed=9651213; DOI=10.1523/jneurosci.18-14-05301.1998;
RA   Berke J.D., Paletzki R.F., Aronson G.J., Hyman S.E., Gerfen C.R.;
RT   "A complex program of striatal gene expression induced by dopaminergic
RT   stimulation.";
RL   J. Neurosci. 18:5301-5310(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, INDUCTION, AND INTERACTION WITH POLR2A; CDC2L
RP   AND SFRS2.
RX   PubMed=11683997; DOI=10.1016/s0896-6273(01)00465-2;
RA   Berke J.D., Sgambato V., Zhu P.-P., Lavoie B., Vincent M., Krause M.,
RA   Hyman S.E.;
RT   "Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an
RT   RNA polymerase II-associated cyclin.";
RL   Neuron 32:277-287(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INDUCTION.
RX   PubMed=12807435; DOI=10.1046/j.1471-4159.2003.01816.x;
RA   Sgambato V., Minassian R., Nairn A.C., Hyman S.E.;
RT   "Regulation of ania-6 splice variants by distinct signaling pathways in
RT   striatal neurons.";
RL   J. Neurochem. 86:153-164(2003).
RN   [5]
RP   INTERACTION WITH CDK12.
RX   PubMed=16537916; DOI=10.1128/mcb.26.7.2736-2745.2006;
RA   Chen H.-H., Wang Y.-C., Fann M.-J.;
RT   "Identification and characterization of the CDK12/cyclin L1 complex
RT   involved in alternative splicing regulation.";
RL   Mol. Cell. Biol. 26:2736-2745(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-336; SER-339 AND SER-353, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Involved in pre-mRNA splicing (PubMed:11683997). Functions in
CC       association with cyclin-dependent kinases (CDKs). May play a role in
CC       the regulation of RNA polymerase II (pol II). Inhibited by the CDK-
CC       specific inhibitor CDKN1A/p21 (By similarity).
CC       {ECO:0000250|UniProtKB:Q9UK58, ECO:0000269|PubMed:11683997}.
CC   -!- SUBUNIT: Interacts with POLR2A via its hyperphosphorylated C-terminal
CC       domain (CTD). Interacts with CDK11A, CDK11B, CDK12 and CDK13. May form
CC       a ternary complex with CDK11B and casein kinase II (CKII). Interacts
CC       with pre-mRNA-splicing factors, including at least SRSF1, SRSF2 AND
CC       SRSF7/SLU7. {ECO:0000250|UniProtKB:Q9UK58, ECO:0000269|PubMed:11683997,
CC       ECO:0000269|PubMed:16537916}.
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:11683997,
CC       ECO:0000269|PubMed:9651213}. Nucleus, nucleoplasm
CC       {ECO:0000250|UniProtKB:Q9UK58}. Note=Found in nuclear intrachromatin
CC       granules clusters (IGC), also called nuclear speckles, which are
CC       storage compartments for nuclear proteins involved in mRNA processing.
CC       {ECO:0000269|PubMed:11683997, ECO:0000269|PubMed:9651213}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Ccnl1 is an immediate-early gene with independently regulated
CC         isoforms.;
CC       Name=1;
CC         IsoId=Q9R1Q2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9R1Q2-2; Sequence=VSP_016128, VSP_016129;
CC   -!- TISSUE SPECIFICITY: Ubiquitous with higher level in liver; expressed in
CC       striatal neurons. {ECO:0000269|PubMed:11683997}.
CC   -!- INDUCTION: By anisomycin (activator of MAP kinase pathway) and by
CC       dopamine and cocaine in dopamine D1 receptor-expressing striatal
CC       neurons and by EGF/epidermal growth factor or NGF/nerve growth factor
CC       in PC12 pheochromocytoma cells. Isoform 1 also is specifically induced
CC       by cycloheximide, potassium chloride (KCl) and forskolin or brain
CC       neurotrophic factor (BDNF). Isoform 2 is induced by glutamate.
CC       {ECO:0000269|PubMed:11683997, ECO:0000269|PubMed:12807435,
CC       ECO:0000269|PubMed:9651213}.
CC   -!- DOMAIN: Contains a RS region (arginine-serine dipeptide repeat) within
CC       the C-terminal domain which is the hallmark of the SR family of
CC       splicing factors. This region probably plays a role in protein-protein
CC       interactions (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the cyclin family. Cyclin L subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF030091; AAD45558.1; -; mRNA.
DR   EMBL; BC085686; AAH85686.1; -; mRNA.
DR   RefSeq; NP_446114.1; NM_053662.3. [Q9R1Q2-1]
DR   RefSeq; XP_003749343.1; XM_003749295.4.
DR   AlphaFoldDB; Q9R1Q2; -.
DR   SMR; Q9R1Q2; -.
DR   STRING; 10116.ENSRNOP00000016016; -.
DR   iPTMnet; Q9R1Q2; -.
DR   PhosphoSitePlus; Q9R1Q2; -.
DR   jPOST; Q9R1Q2; -.
DR   PaxDb; 10116-ENSRNOP00000016016; -.
DR   Ensembl; ENSRNOT00000016016.6; ENSRNOP00000016016.2; ENSRNOG00000011586.8. [Q9R1Q2-1]
DR   Ensembl; ENSRNOT00055007204; ENSRNOP00055005370; ENSRNOG00055004549. [Q9R1Q2-1]
DR   Ensembl; ENSRNOT00060001867; ENSRNOP00060001077; ENSRNOG00060001293. [Q9R1Q2-1]
DR   Ensembl; ENSRNOT00065043471; ENSRNOP00065035663; ENSRNOG00065025229. [Q9R1Q2-1]
DR   GeneID; 114121; -.
DR   KEGG; rno:114121; -.
DR   UCSC; RGD:620864; rat. [Q9R1Q2-1]
DR   AGR; RGD:620864; -.
DR   CTD; 57018; -.
DR   RGD; 620864; Ccnl1.
DR   eggNOG; KOG0835; Eukaryota.
DR   GeneTree; ENSGT00940000159135; -.
DR   HOGENOM; CLU_022000_6_1_1; -.
DR   InParanoid; Q9R1Q2; -.
DR   OrthoDB; 4848076at2759; -.
DR   PhylomeDB; Q9R1Q2; -.
DR   TreeFam; TF101011; -.
DR   PRO; PR:Q9R1Q2; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000011586; Expressed in thymus and 20 other cell types or tissues.
DR   ExpressionAtlas; Q9R1Q2; baseline and differential.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme complex; ISO:RGD.
DR   GO; GO:0016607; C:nuclear speck; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IBA:GO_Central.
DR   GO; GO:0043484; P:regulation of RNA splicing; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   Gene3D; 1.10.472.10; Cyclin-like; 2.
DR   InterPro; IPR013763; Cyclin-like_dom.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR043198; Cyclin/Ssn8.
DR   InterPro; IPR004367; Cyclin_C-dom.
DR   InterPro; IPR006671; Cyclin_N.
DR   PANTHER; PTHR10026; CYCLIN; 1.
DR   PANTHER; PTHR10026:SF64; CYCLIN-L1; 1.
DR   Pfam; PF02984; Cyclin_C; 1.
DR   Pfam; PF00134; Cyclin_N; 1.
DR   PIRSF; PIRSF036580; Cyclin_L; 1.
DR   SMART; SM00385; CYCLIN; 2.
DR   SMART; SM01332; Cyclin_C; 1.
DR   SUPFAM; SSF47954; Cyclin-like; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cyclin; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..527
FT                   /note="Cyclin-L1"
FT                   /id="PRO_0000080482"
FT   REGION          1..37
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          89..191
FT                   /note="Cyclin-like 1"
FT   REGION          204..288
FT                   /note="Cyclin-like 2"
FT   REGION          327..527
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          391..433
FT                   /note="RS"
FT   COMPBIAS        344..371
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        391..417
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        433..449
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        462..476
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        506..527
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         326
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK58"
FT   MOD_RES         336
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         339
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         353
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         356
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK58"
FT   MOD_RES         375
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK58"
FT   MOD_RES         446
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK58"
FT   CROSSLNK        340
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK58"
FT   CROSSLNK        348
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK58"
FT   CROSSLNK        363
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK58"
FT   VAR_SEQ         164..173
FT                   /note="RTPSPLILDQ -> SDQLHLPKPG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11683997,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_016128"
FT   VAR_SEQ         174..527
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11683997,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_016129"
SQ   SEQUENCE   527 AA;  59791 MW;  444F5D632B15BC43 CRC64;
     MASGPHPTST AAAASASSAA PSAGGSSSGT TTTTTTTTGG ILIGDRLYSE VSLTIDHSVI
     PEERLSPTPS MQDGLDLPSE TDLRILGCEL IQAAGILLRL PQVAMATGQV LFHRFFYSKS
     FVKHSFEIVA MACINLASKI EEAPRRIRDV INVFHHLRQL RGKRTPSPLI LDQNYINTKN
     QVIKAERRVL KELGFCVHVK HPHKIIVMYL QVLECERNQT LVQTAWNYMN DSLRTNVFVR
     FQPETIACAC IYLAARALQI PLPTRPHWFL LFGTTEEEIQ EICIETLRLY TRKKPNYELL
     EKEVEKRKVA LQEAKLKAKG LNLDGTPALS TLGGFSPASK PSSPREVKAE EKSPVSINVK
     TVKKEPEDRQ QASKSPYNGV RKDSKRSRNS RSASRSRSRT RSRSRSHTPR RHYNNRRSRS
     GTYSSRSRSR SRSHSESPRR HHNHGSPHLK AKHTREDLKS SNRHGHKRKK SRSRSQSKTR
     DHSDVTKKHR HERGHHRDRR ERSRSFERSH KGKHHGGSRS GHGRHRR
//
